Fairvalue-Calculator Fairvalue-Calculator
EN DE

Boditech Med Inc (206640) Fair Value & Analysis

Healthcare · KR · Market cap 224B KRW

Price9,800 KRW
Fair Value21,816 KRW
Upside+122.6%
Quality88/100
Evidence: Medium Range 15,271 KRW – 28,361 KRW

Fair value as of: Jun 25, 2026

Analysis

Boditech Med Inc (206640) currently trades at 9,800 KRW, while our model-based Fair Value estimate is 21,816 KRW — implying the stock looks roughly 122.6% undervalued today. We read business quality at 88/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges; ichroma-50, an automated immunoassay system with high-throughput; Hemochroma PLUS, a handheld device that can run tests for anemia; portable analyzers ichroma M3 and ichroma M2; and NuActor, an automated nucleic acid extraction system. It also provides compact immunoassay analyzers, including AFIAS-1, AFIAS-3, AFIAS-6, and AFIAS-10; cardiac reagents; cancer reagents; COVID-19 reagents; diagnostic reagents; reagents for hormones, infections, a…

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Boditech Med Inc (206640) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 21,816 KRW versus a price of 9,800 KRW — about +123% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 206640?
Our 21-model fair value for Boditech Med Inc is 21,816 KRW (as of Jun 25, 2026), built from audited fundamentals. The current price is 9,800 KRW.
What is the quality score of 206640?
Boditech Med Inc has a Quality Score of 88/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.